Towards dynamic risk assessments in lung cancer screening

IF 7.7 1区 医学 Q1 RESPIRATORY SYSTEM
Thorax Pub Date : 2025-06-08 DOI:10.1136/thorax-2025-223403
Kevin ten Haaf
{"title":"Towards dynamic risk assessments in lung cancer screening","authors":"Kevin ten Haaf","doi":"10.1136/thorax-2025-223403","DOIUrl":null,"url":null,"abstract":"Various lung cancer screening programmes and pilot studies are being implemented worldwide.1 Many of these programmes have identified and screened their first selection of individuals that meet the defined criteria for screening eligibility. Regardless of the chosen criteria, there will always be a group of individuals with risks close to but below the cut-off for eligibility, who may reach the eligibility threshold in future years. Approaches for risk reassessment of these individuals should be efficient in order to limit the costs and potential distress of contacting these individuals.2 Consequently, the study by Kumarasamy et al provides a timely and pragmatic approach for evaluating whether and when to reassess these ‘near-miss’ individuals.3 The study evaluated individuals who were approached for the International Lung Screening Trial from seven sites across Australia, Canada and Hong Kong, but were ineligible due to having a PLCOm2012 risk score of less than 1.51%.4 5 It finds that about 50.3% of these individuals reach this risk score before age 80, while 38.7% and 26.9% would do so before ages 75 and 70, respectively. Overall, of the participants eligible by age 80, 69.0% reached the 1.51% risk score within 10 years …","PeriodicalId":23284,"journal":{"name":"Thorax","volume":"40 1","pages":""},"PeriodicalIF":7.7000,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thorax","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/thorax-2025-223403","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Various lung cancer screening programmes and pilot studies are being implemented worldwide.1 Many of these programmes have identified and screened their first selection of individuals that meet the defined criteria for screening eligibility. Regardless of the chosen criteria, there will always be a group of individuals with risks close to but below the cut-off for eligibility, who may reach the eligibility threshold in future years. Approaches for risk reassessment of these individuals should be efficient in order to limit the costs and potential distress of contacting these individuals.2 Consequently, the study by Kumarasamy et al provides a timely and pragmatic approach for evaluating whether and when to reassess these ‘near-miss’ individuals.3 The study evaluated individuals who were approached for the International Lung Screening Trial from seven sites across Australia, Canada and Hong Kong, but were ineligible due to having a PLCOm2012 risk score of less than 1.51%.4 5 It finds that about 50.3% of these individuals reach this risk score before age 80, while 38.7% and 26.9% would do so before ages 75 and 70, respectively. Overall, of the participants eligible by age 80, 69.0% reached the 1.51% risk score within 10 years …
肺癌筛查中的动态风险评估
世界各地正在实施各种肺癌筛查方案和试点研究其中许多规划已经确定并筛选了第一批符合确定的筛选资格标准的个人。不管选择的标准是什么,总会有一群人的风险接近但低于资格的截止值,他们可能在未来几年达到资格门槛。对这些人进行风险重新评估的方法应该是有效的,以限制与这些人接触的成本和潜在的痛苦因此,Kumarasamy等人的研究提供了一个及时和实用的方法来评估是否以及何时重新评估这些“险些”的个体该研究评估了从澳大利亚、加拿大和香港的7个地点进行国际肺筛查试验的个体,但由于PLCOm2012风险评分低于1.51%而不符合资格。研究发现,这些人中约有50.3%的人在80岁之前达到这一风险评分,而在75岁和70岁之前分别达到38.7%和26.9%。总的来说,在80岁的参与者中,69.0%的人在10年内达到了1.51%的风险评分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Thorax
Thorax 医学-呼吸系统
CiteScore
16.10
自引率
2.00%
发文量
197
审稿时长
1 months
期刊介绍: Thorax stands as one of the premier respiratory medicine journals globally, featuring clinical and experimental research articles spanning respiratory medicine, pediatrics, immunology, pharmacology, pathology, and surgery. The journal's mission is to publish noteworthy advancements in scientific understanding that are poised to influence clinical practice significantly. This encompasses articles delving into basic and translational mechanisms applicable to clinical material, covering areas such as cell and molecular biology, genetics, epidemiology, and immunology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信